Cellectis SA (NASDAQ:CLLS)
| 2.19 BATS BZX Real-Time Price As of 11:13am ET |  -0.04 / -1.79%Today’s Change | 2.00 Today|||52-Week Range 9.57 | -73.03% Year-to-Date |
Latest CLLS News | Press Releases
No recent news for Cellectis SA.
Today’s Trading
| Previous close | 2.23 |
| Today’s open | 2.18 |
| Day’s range | 2.18 - 2.19 |
| Volume | 173 |
| Average volume (3 months) | 96,989 |
| Market cap | $99.2M |
Data as of 11:13am ET, 12/07/2022
Growth & Valuation
| Earnings growth (last year) | -33.57% |
| Earnings growth (this year) | +5.02% |
| Earnings growth (next 5 years) | +1.50% |
| Revenue growth (last year) | -22.52% |
| P/E ratio | NM |
| Price/Sales | 6.35 |
| Price/Book | 0.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GMDAGamida Cell Ltd | -0.11 | -7.75% |
| CAPRCapricor Therapeutic... | +0.14 | +3.45% |
| ---- | ||
| OPNTOpiant Pharmaceutica... | +0.01 | +0.05% |
Data as of 11:21am ET, 12/07/2022
Financials
| Next reporting date | March 7, 2023 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $57.3M |
| Annual profit (last year) | -$114.2M |
| Net profit margin | -199.32% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
